期刊文献+

Marc-145细胞微载体悬浮培养消化放大技术研究 被引量:2

Research on the scale-up technique of microcarrier suspension culture and digestion of Marc-145 cells
原文传递
导出
摘要 为了建立Marc-145细胞微载体培养放大技术,使其用于猪繁殖与呼吸综合征(porcine reproductive and respiratory syndrome,PRRS)疫苗的规模化生产,试验在7 L生物反应器内微载体培养Marc-145种子细胞,再用胰蛋白酶消化,然后进行逐级放大培养,并通过细胞最佳消化状态试验、保留胰蛋白酶消化液的影响试验、测试回收微载体试验等方法摸索胰蛋白酶消化放大技术参数。结果表明:Marc-145细胞在初级生物反应器内培养时,微载体使用量为5 g/L,细胞密度达3.18×10^6个/mL,并且在状态饱满时进行消化放大;在14 L生物反应器内培养时,Marc-145细胞均匀分布在微载体上并且代谢旺盛,在细胞密度为2.91×10^6个/mL时进行14 L消化放大;在14 L生物反应器内培养Marc-145细胞时,采用批培养方式,细胞比生长速率最大达0.031/h,在培养96小时时细胞密度达2.37×10^6个/mL。说明试验成功建立了生物反应器微载体培养Marc-145细胞的胰蛋白酶消化放大技术,并实现了逐级放大。 In order to establish the scale-up technique of microcarrier suspension culture of Marc-145 cells for the application of vaccine scale production of porcine reproductive and respiratory syndrome, a 7-liter bioreactor was used in this experiment for the microcarrier culture of seed Marc-145 cells,and then was digested with trypsin before the scale-up culture step by step. The scale-up technological parameters on trypsinization were explored through the methods including cell optimum digestion test,trypsin digestive liquid retaining effect test,microcarrier recovery measurement test. The results showed that when Marc-145 cells were cultured in the primary bioreactor,the amount of microcarriers was 5 g/L,and cell density was 3.18×10^6 cells/mL;then reaching full cell morphology,scale-up culture was carried out after digestion. When cultured in 14 L bioreactor,Marc-145 cells were uniformly distributed on microcarriers and were highly metabolized;when reaching a density of 2.91×10^6 cells/mL,the cells were scale-up inoculated to the tertiary bioreactor. When Marc-145 cells were cultured in 14 L bioreactor,batch culture mode was used and the specific cell growth rate reached the peak of 0.031/h;when 96 h post inoculation,cell density reached 2.37×10^6 cells/mL. The results indicated that the scale-up technique of microcarrier suspension culture and digestion of Marc-145 cells in the bioreactors was successfully established and the scale-up culture was achieved step by step.
作者 尹茉莉 张爽 王振军 冯二凯 冷雪 王会岩 李艳 孙美艳 YIN Moli;ZHANG Shuang;WANG Zhenjun;FENG Erkai;LENG Xue;WANG Huiyan;LI Yan;SUN Meiyan(Jilin Collaborative Innovation Center for Antibody Engineering,Jilin Medical University,Jilin 132013,China;Jilin City GardenManagement Center, Jilin 132013, China;Institute of Special Animal and Plant Sciences, Chinese Academy of AgriculturalSciences, Changchun 130112, China;Jilin Agricultural University, Changchun 130112, China;Academy of Laboratory Jilin Medical University,Jilin 132013,China)
出处 《黑龙江畜牧兽医》 CAS 北大核心 2019年第13期16-20,172,共6页 Heilongjiang Animal Science And veterinary Medicine
基金 吉林省教育厅“十三五”科学技术项目(JJKH20180822KJ)
关键词 MARC-145细胞 生物反应器 微载体 胰蛋白酶 放大技术 猪繁殖与呼吸综合征病毒 Marc - 145 cell bioreactor microcarrier trypsin the scale-up technique Porcine reproductive and respiratory syndrome virus
  • 相关文献

参考文献5

二级参考文献41

  • 1吴浩飞,杨晓明,黄仕和.Vero细胞作为基质的病毒性疫苗研制进展[J].微生物学免疫学进展,2011,39(3):56-63. 被引量:5
  • 2杨涛,刘明,张云,刘春国,王洪峰,蔡雪辉.重组H5N3禽流感疫苗株在MDCK细胞中大规模增殖条件研究[J].中国预防兽医学报,2007,29(3):199-203. 被引量:14
  • 3Knop D R,Heather H.Bioreactor production of recombinant herpes simplex virus vectors[J].Biotechnol Prog,2007,23(3):715-721.
  • 4Morrow J R.Advances in antibody manufacturing using mammalian cells[J].Biotechnol Annu Rev,2007,13:95-113.
  • 5Wurm F M.Production of recombinant protein therapeutics in cultivated mammalian cells[J].Nat Biotechnol,2004,22:1393-1398.
  • 6Genzel Y,Fischer M,Reichl U.Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture[J].Vaccine,2006,24:3261-3272.
  • 7Seletzky J M,Noak U,Fricke J,et al.Scale-up from shake flasks to fermenters in batch and continuous mode with Corynebacterium glutamicum on lactic acid based on oxygen transfer and pH[J].Biotechnol Bioeng,2007,98(4):800-811.
  • 8Kitaya Y,Kibe S,Oguchi M,et al.Effects of CO2 and O2 concentrations and light intensity on growth of microalgae (Euglena gracilis) in CELSS[J].Life Support Biosph Sci,1998,5:243-247.
  • 9Yang J D,Angelillo Y,Chaudhry M,et al.Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process[J].Biotechnol Bioeng,2000,69:74-82.
  • 10Mercille S,Johnson M,Lanthier S,et al.Understanding factors that limit the productivity of suspension-based perfusion cultures operated at high medium renewal rates[J].Biotechnol Bioeng,2000,67:435-450.

共引文献29

同被引文献5

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部